Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Ahlin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2011
Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapyPia Wegman, Cecilia Ahlin, Bengt Sorbe
Oncology Letters|September 10, 2014
Natural history of recurrences in endometrial carcinomaBengt Sorbe, Christian Juresta, Cecilia Ahlin
Oncotarget|September 1, 2016
Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapyLouise Bohr Mordhorst, Cecilia Ahlin, Bengt Sorbe
Anticancer Research|November 17, 2012
A study of serum biomarkers associated with relapse of cervical cancerLouise Bohr Mordhorst, Bengt Sorbe, Cecilia Ahlin
Gynecologic Oncology|August 27, 2014
Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapyLouise Bohr Mordhorst, Cecilia Ahlin, Bengt Sorbe
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Aberrant expression of cyclin E in low-risk node negative breast cancerCecilia Ahlin, Bettina Gruhne, Marit Holmqvist, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2014
Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control studyClaudia Lundgren, Cecilia Ahlin, Lars Holmberg, et al.
Breast Cancer Research and Treatment|May 22, 2017
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancersCecilia Ahlin, Claudia Lundgren, Elin Embretsén-Varro, et al.
Plos One|April 19, 2017
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancerMalin Grönberg, Cecilia Ahlin, Ylva Naeser, et al.
Breast Cancer Research and Treatment|February 19, 2011
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancerCarina Strand, Cecilia Ahlin, Pär-Ola Bendahl, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2011
Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapyPia Wegman, Cecilia Ahlin, Bengt Sorbe
Oncology Letters|September 10, 2014
Natural history of recurrences in endometrial carcinomaBengt Sorbe, Christian Juresta, Cecilia Ahlin
Oncotarget|September 1, 2016
Prognostic impact of the expression of Wnt-signaling proteins in cervical carcinoma FIGO stage I-IV treated with radiotherapy or chemoradiotherapyLouise Bohr Mordhorst, Cecilia Ahlin, Bengt Sorbe
Anticancer Research|November 17, 2012
A study of serum biomarkers associated with relapse of cervical cancerLouise Bohr Mordhorst, Bengt Sorbe, Cecilia Ahlin
Gynecologic Oncology|August 27, 2014
Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapyLouise Bohr Mordhorst, Cecilia Ahlin, Bengt Sorbe
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Aberrant expression of cyclin E in low-risk node negative breast cancerCecilia Ahlin, Bettina Gruhne, Marit Holmqvist, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2014
Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control studyClaudia Lundgren, Cecilia Ahlin, Lars Holmberg, et al.
Breast Cancer Research and Treatment|May 22, 2017
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancersCecilia Ahlin, Claudia Lundgren, Elin Embretsén-Varro, et al.
Plos One|April 19, 2017
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancerMalin Grönberg, Cecilia Ahlin, Ylva Naeser, et al.
Breast Cancer Research and Treatment|February 19, 2011
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancerCarina Strand, Cecilia Ahlin, Pär-Ola Bendahl, et al.
Pageof 2